These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23771630)

  • 1. Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.
    Riganti C; Salaroglio IC; Pinzòn-Daza ML; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Couraud PO; Bosia A; Ghigo D; Schiffer D
    Cell Mol Life Sci; 2014 Feb; 71(3):499-516. PubMed ID: 23771630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
    Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
    Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.
    Pinzón-Daza ML; Salaroglio IC; Kopecka J; Garzòn R; Couraud PO; Ghigo D; Riganti C
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1258-69. PubMed ID: 24896565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
    Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
    Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.
    Salaroglio IC; Gazzano E; Kopecka J; Chegaev K; Costamagna C; Fruttero R; Guglielmo S; Riganti C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
    Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
    PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines.
    Balaguer TM; Gómez-Martínez A; García-Morales P; Lacueva J; Calpena R; Reverte LR; Riquelme NL; Martinez-Lacaci I; Ferragut JA; Saceda M
    BMC Mol Biol; 2012 Jul; 13():25. PubMed ID: 22846052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier.
    Colclough N; Alluri RV; Tucker JW; Gozalpour E; Li D; Du H; Li W; Harlfinger S; O'Neill DJ; Sproat GG; Chen K; Yan Y; McGinnity DF
    Drug Metab Dispos; 2024 Jan; 52(2):95-105. PubMed ID: 38071533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
    Gericke B; Borsdorf S; Wienböker I; Noack A; Noack S; Löscher W
    Fluids Barriers CNS; 2021 Aug; 18(1):36. PubMed ID: 34344390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
    Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
    Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
    Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
    Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells.
    Lim JC; Kania KD; Wijesuriya H; Chawla S; Sethi JK; Pulaski L; Romero IA; Couraud PO; Weksler BB; Hladky SB; Barrand MA
    J Neurochem; 2008 Aug; 106(4):1855-65. PubMed ID: 18624906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier.
    Hembury A; Mabondzo A
    Cell Mol Neurobiol; 2008 Nov; 28(7):915-21. PubMed ID: 18379872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.
    Agarwal S; Mittapalli RK; Zellmer DM; Gallardo JL; Donelson R; Seiler C; Decker SA; Santacruz KS; Pokorny JL; Sarkaria JN; Elmquist WF; Ohlfest JR
    Mol Cancer Ther; 2012 Oct; 11(10):2183-92. PubMed ID: 22891038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
    Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
    J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
    Schaich M; Kestel L; Pfirrmann M; Robel K; Illmer T; Kramer M; Dill C; Ehninger G; Schackert G; Krex D
    Ann Oncol; 2009 Jan; 20(1):175-81. PubMed ID: 18687982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells.
    Pinzón-Daza M; Garzón R; Couraud P; Romero Ia; Weksler B; Ghigo D; Bosia A; Riganti C
    Br J Pharmacol; 2012 Dec; 167(7):1431-47. PubMed ID: 22788770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling.
    Verscheijden LFM; Koenderink JB; de Wildt SN; Russel FGM
    Arch Toxicol; 2021 Sep; 95(9):3015-3029. PubMed ID: 34268580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.